YEAST-VITE |
METHYLTHEOBROMINE |
CAFFEINE MELTING POINT STANDARD |
NODOZ |
ZANTHINE |
CAFFEINE |
PRO-PLUS |
THEINE |
CAFCIT |
ANHYDROUS CAFFEINE |
NSC-5036 |
FEMA NO. 2224 |
NODOZ CAPLETS AND CHEWABLE TABLETS |
COFFEINE |
1,3,7-TRIMETHYL-3,7-DIHYDRO-1H-PURINE-2,6-DIONE |
3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURINE-2,6-DIONE |
7-METHYL THEOPHYLLINE |
CAFÉINE |
COFFEINUM |
LANORINAL |
METHYLTHEOBROMIDE |
1-METHYLTHEOBROMINE |
1,3,7-TRIMETHYL-2,3,6,7-TETRAHYDRO-1H-PURINE-2,6-DIONE |
TEÍNA |
PROPOXYPHENE |
COFFEIN |
7-METHYLTHEOPHYLLINE |
1,3,7-TRIMETHYL-2,6-DIOXOPURINE |
ANHYDROUS CAFFEINE (JP15) |
THEIN |
HYCOMINE |
1,3,7-TRIMETHYLXANTHINE |
GUARANINE |
KOFFEIN |
CAFEÍNA |
MATEÍNA |
MONOHYDRATE CAFFEINE |
1-METHYL-THEOBROMINE |
METHYLXANTHINE THEOPHYLLINE |
1,3,7-TRIMETHYLPURINE-2,6-DIONE |
CAFFEINUM |
3,7-DIHYDRO-1,3,7-TRIMETHYL-1H-PURIN-2,6-DION |
1,3,7-TRIMETHYLPURINE-2,6-QUINONE |
chemidplus:58-08-2 |
rxcui:1886 |
drugbank:00201 |
pubchem.compound:2519 |
chembl:CHEMBL113 |
FDA Approval | not approved by the FDA |
Drug Class | small molecule |
Drug Indications | Central Nervous System Stimulants |
Year of Approval | not approved by the fda |
Drug Class | central nervous system stimulants |
n/a |
multitarget |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Adenosine receptor antagonist |
multitarget |
antagonist (inhibitory) |
Direct Interaction | yes |
Mechanism of Interaction | Adenosine receptor antagonist |
Trial Name | - |
inhibitor (inhibitory) |
Trial Name | - |
Novel drug target | Established target |
antagonist (inhibitory) |
Mechanism of Interaction | Adenosine receptor antagonist |
Direct Interaction | yes |
Trial Name | - |
antagonist (inhibitory) |
Mechanism of Interaction | Adenosine receptor antagonist |
Direct Interaction | yes |
CAFFEINE | Primary Drug Name |
Drug Class | central nervous system stimulants |
Year of Approval | not approved by the fda |
Drug Indications | Central Nervous System Stimulants |
Drug Class | small molecule |
FDA Approval | not approved by the FDA |
C328 | NCI drug code |
CHEMBL113 | ChEMBL Drug ID |
D0B3HD | TTD Drug ID |